hims retatrutide The trillion-dollar peptide. Appearing on @tbpn, Andrew Huberman said could be the peptide that “changes everything.” Now in Phase III clinical trials, it's shown up to 30% body weight loss in Hims vs Ro Weight Loss

Adriaenssens AE, Biggs EK, Darwish T, Tadross J, Sukthankar T, Girish M, et al

For most, spacing meals, eating smaller meals, or changing to bland foods alleviated these problems

For how options compare in practice, see Mounjaro vs Wegovy and our weight loss treatments overview

The term does not describe a third GLP receptor

Designed to inhibit DPP-4, the enzyme found to degrade GLP-1 (7-37), this drug, generically called sitagliptin, was developed at Merck by its first research team solely led by women

SeekPeptides has compiled the most comprehensive resource available on this topic, pulling from Phase 2 trial data published in the New England Journal of Medicine, emerging case series on GLP-1 allodynia , and practical management protocols from researchers navigating this exact situation